DailyIQ
|
Last updatedUpdating…

ARWR·Arrowhead Pharmaceuticals Inc.

$88.87
+2.14 (+2.47%)
After Hours
High
$90.21
Open
$88.00
Market Cap
12.21B
52W High
$95.49
Low
$87.05
P. Close
$88.87
P/E
-
52W Low
$20.45
Fwd P/E
-18.20
DailyIQ Est.
$113.36
Inst. Ownership
-
Short Interest
6.88%
Technical Score (1D)
73
BUY
News Sentiment
45
MIXED
Arrowhead Pharmaceuticals’ senior director Michael S. Perry sold 11,600 shares of ARWR for $1,012,680, a move that cuts his stake to 111,459 shares. The divestiture, filed as a Form 4 ten hours ago, signals a notable shift in insider ownership that can alter short‑term market sentiment. A large insider sale often raises questions about the company’s outlook, liquidity needs, or personal financial planning, all of which can influence traders’ risk appetite. In the next 1–10 trading days, the market may react to any perceived loss of confidence from a key executive, potentially tightening the bid‑ask spread or increasing volatility. Traders should watch for any subsequent insider filings that could confirm a pattern of selling or, conversely, a rebound in holdings that might restore confidence. Additionally, any corporate commentary or earnings guidance released in the coming days could clarify whether the sale was driven by company fundamentals or personal reasons. Monitoring the company’s press releases and analyst calls will help determine if the insider sale reflects broader strategic concerns. Finally, keep an eye on the broader biotech sector’s sentiment, as a high‑profile insider sale can spill over into peer stocks and affect sector rotation.

EPS

EstBeatMiss
$-1.73$-1.28$-0.84$-0.40$0.05Q3'25Q4'26
QtrEstActual+/−
Q4'26$-1.52 - -
Q3'25$-0.16$-0.18-14.5%

Revenue

EstBeatMiss
$42M$103M$163M$224M$284MQ3'25Q4'26
QtrEstActual+/−
Q4'26$70M - -
Q3'25 - $256M -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

ARWR Stock Snapshot

ARWR is currently trading at $88.88, giving Arrowhead Pharmaceuticals Inc. a market cap of 12.21B. Today's range spans $87.05–$90.21, with shares opening at $88.00 and moving up $0.01 (0.0%) from the prior close. DailyIQ's technical score sits at 73/100 (BUY) with a news sentiment reading of 45/100.

Over the past year ARWR has traded between $20.45 and $95.49 - the current price is +334.6% off the 52-week low and -6.9% from the high. 22 analysts cover the stock with a Buy consensus and a mean 12-month target of $110.18 (range $100.00–$126.00), implying upside of +24.0%.

ARWR is showing the kind of bullish setup that active managers add to on dips - 73/100 (BUY), neutral sentiment at 45/100, 12.21B market cap in the broader market, price $88.88 (near 52-week highs). At this cap tier, the combination of technical confirmation and positive sentiment is what separates speculative bullish positions from high-conviction ones. Annual range: $20.45–$95.49. The setup is in the latter category.

The combination of a BUY signal (73/100) and neutral news sentiment (45/100) puts ARWR on the screens of active managers who run quality-momentum overlays, a cohort that can build meaningful positions at 12.21B in the broader market market cap without immediately moving the stock. At $88.88 (near 52-week highs in the $20.45–$95.49 range), the entry discipline is clean and the potential re-rating if sentiment continues to improve is meaningful.